4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Cancer of Esophagus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, YT; Hecht, SS; Knezevich, AD; Stepanov, I; Wang, R; Yuan, JM | 1 |
| Hecht, SS; Murphy, SE; Nelson, HH; Stepanov, I; Yuan, JM | 1 |
2 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Cancer of Esophagus
| Article | Year |
|---|---|
Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.
Topics: Alcohol Drinking; Biomarkers; Carcinogens; Esophageal Neoplasms; Glucuronides; Humans; Male; Middle Aged; Nitrosamines; Prospective Studies; Pyridines; Risk; Smoking | 2011 |
Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai cohort study.
Topics: Biomarkers; Cohort Studies; Cotinine; Esophageal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Nicotiana; Nitrosamines; Odds Ratio; Pyridines; Risk Factors; Smoking | 2013 |